1. Membrane Transporter/Ion Channel Autophagy
  2. CFTR Autophagy
  3. Elexacaftor

Elexacaftor  (Synonyms: VX-445)

製品番号: HY-111772 純度: 99.26%
COA 取扱説明書 Technical Support

Elexacaftor (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). Elexacaftor (VX-445, Compound 1) facilitates the processing and trafficking of CFTR to increase the amount of CFTR at the cell surface.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 2216712-66-0

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 408 在庫あり
Solution
10 mM * 1 mL in DMSO USD 408 在庫あり
Solid
1 mg $110 在庫あり
5 mg $310 在庫あり
10 mg $500 在庫あり
25 mg $975 在庫あり
50 mg $1360 在庫あり
100 mg $1850 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 48 publication(s) in Google Scholar

Other Forms of Elexacaftor:

Top Publications Citing Use of Products

顧客検証

WB
Bio/Physico-chemical Assay
Others

    Elexacaftor purchased from MedChemExpress. Usage Cited in: JCI Insight. 2026 Mar 23;11(6):e198846.

    Representative immunogold electron microscopy images showing the distribution of overexpressed F508del-CFTR-GFP in HEK293T cells. Cells were treated for 24 hours with DMSO (Veh), ETI (3 μM VX-445, 10 μM VX-661, and 1 μM VX-770) plus control peptide (ETI + 25 μM CP), or ETI plus PI3Kγ MP (ETI + 25 μM PI3Kγ MP). HEK293T cells expressing WT CFTR-GFP served as positive controls.

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Jul 2:e176328.  [Abstract]

    Subsequent to amiloride, short-circuit current (Isc) was increased by the C2 CFTR correctors VX-445 (10 μM).

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Jul 2:e176328.  [Abstract]

    Recording of force in millinewtons (mN) over time from a single mesenteric artery showing preconstriction with the prostaglandin mimetic U46619 (1 × 10−7 to 5 × 10−7 M), after which the ability of increasing concentrations of VX-445 (Elexacaftor) to induce vasorelaxation was assessed. We added 0 Ca2+ at the end to determine maximal vasorelaxation.

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Cyst Fibros. 2023 May;22(3):525-537.

    Elexacaftor/Tezacaftor (elexa/teza; 3 μM/10 μM; 24 h) combination causes a significant increase in the expression of the mature protein, with no changes in the expression of the immature, core-glycosylated form (B band) in Epithelia.

    Elexacaftor purchased from MedChemExpress. Usage Cited in: Am J Respir Crit Care Med. 2021 Nov 15;204(10):1231-1235.  [Abstract]

    Western blot of CFTR variances transiently expressed in HEK293 (left) or CFBE (right) cells. Cells were transfected with indicated CFTR variances overnight and then treated with VX445 (Elexacaftor: 2 μM) /VX661 or DMSO for 24 hours.

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2021 Aug 16;131(16):e150398.  [Abstract]

    Human airway epithelia from CFTR-ΔF508 donors were treated for 48 hours with a combination of elexacaftor (3 μM), tezacaftor (18 μM), and ivacaftor (1 μM), either alone or in the presence of TNF-α+IL-17. pHASL was measured using SNARF-1-dextran.
    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Elexacaftor (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). Elexacaftor (VX-445, Compound 1) facilitates the processing and trafficking of CFTR to increase the amount of CFTR at the cell surface[1].

    IC50 & Target

    CFTR[1].

    体外実験

    Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore Phe508del CFTR protein function. Elexacaftor (VX-445) has the potential to treat cystic fibrosis. VX-445-Tezacaftor-VX-770 significantly improves Phe508del CFTR protein processing, trafficking, and chloride transport to a greater extent than any two of these agents in dual combination[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    臨床実験
    分子量

    597.65

    分子式

    C26H34F3N7O4S

    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    CC1(C)C[C@H](C)CN1C2=C(C(NS(C3=CN(C)N=C3C)(=O)=O)=O)C=CC(N4C=CC(OCC(C)(C(F)(F)F)C)=N4)=N2

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 125 mg/mL (209.15 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.6732 mL 8.3661 mL 16.7322 mL
    5 mM 0.3346 mL 1.6732 mL 3.3464 mL
    10 mM 0.1673 mL 0.8366 mL 1.6732 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (3.48 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.08 mg/mL (3.48 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.6732 mL 8.3661 mL 16.7322 mL 41.8305 mL
    5 mM 0.3346 mL 1.6732 mL 3.3464 mL 8.3661 mL
    10 mM 0.1673 mL 0.8366 mL 1.6732 mL 4.1831 mL
    15 mM 0.1115 mL 0.5577 mL 1.1155 mL 2.7887 mL
    20 mM 0.0837 mL 0.4183 mL 0.8366 mL 2.0915 mL
    25 mM 0.0669 mL 0.3346 mL 0.6693 mL 1.6732 mL
    30 mM 0.0558 mL 0.2789 mL 0.5577 mL 1.3944 mL
    40 mM 0.0418 mL 0.2092 mL 0.4183 mL 1.0458 mL
    50 mM 0.0335 mL 0.1673 mL 0.3346 mL 0.8366 mL
    60 mM 0.0279 mL 0.1394 mL 0.2789 mL 0.6972 mL
    80 mM 0.0209 mL 0.1046 mL 0.2092 mL 0.5229 mL
    100 mM 0.0167 mL 0.0837 mL 0.1673 mL 0.4183 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Elexacaftor
    製品番号:
    HY-111772
    数量:
    MCE 日本正規代理店: